T-E Meds, an Immunwork’s affiliated company, has been selected as a finalist for the Start-up Stadium pitching competition in the BIO International Convention.
T-E Meds stands out through its innovative “Multi-Arm Linker” technology platform. This technology can be utalized to design and create novel ADC/ARC drugs to improve the efficacy and safety.
T-E Meds was also selected as a exhibitor of the National Science Council representative team and will participate in the exhibition in Boston on June 5th to 8th, 2023. This is an incredible opportunity to connect with us and gain valuable insights into our innovative technology and cutting-edge drug development.
News website links: